Position
Creative Planning in Ascendis Pharma A/S
Back to the book · All holders of ASND
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $105.2K$213.24 → $228.73
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.79K | $1.45M | — | — | — | 0.0% |
| Q1 2026 | 7.95K | $1.82M | $228.73 | $105.2K | $265.8K | 0.0% |